| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.26 | 0.04 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |